BYOM JOHN E
Known title: DirectorCIK: 0001202329
Associated companies
Transaction History
| PBH | ▲ Buy | Grant | 2,981 | $0 | 8/4/2026 | View on chart |
| PBH | ▼ Sell | Open Market | 3,000 | $178K | 11/25/2025 | View on chart |
| PBH | ▲ Buy | Grant | 2,094 | $0 | 8/5/2025 | View on chart |
| PBH | ▲ Buy | Grant | 2,202 | $0 | 8/6/2024 | View on chart |
| PBH | ▲ Buy | Grant | 2,295 | $0 | 8/1/2023 | View on chart |
| PBH | ▲ Buy | Grant | 2,495 | $0 | 8/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Prestige Consumer Healthcare Reports Q1 2027 Earnings
Prestige Consumer Healthcare released the transcript of its Q1 2027 earnings call. The company discussed its quarterly results and outlook, providing detailed guidance on revenue, earnings, and future plans. The release offers investors a clearer view of the company's performance and strategy.
Prestige Consumer Healthcare Reports Q1 2027 Earnings. Prestige Consumer Healthcare released the transcript of its Q1 2027 earnings call. The company discussed its quarterly results and outlook, providing detailed guidance on revenue, earnings, and future plans. The release offers investors a clearer view of the company's performance and strategy.